{
  "trial_id": "NCT02304302",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Cytogenetically documented Trisomy 21 or Complete Unbalanced Translocation of Chromosome 21.",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "No pregnancy by serum testing at screening. Females of child-bearing potential, sexually active must be practicing a reliable method of birth control.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Laboratory findings within normal limits or judged clinically insignificant at baseline",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Vital signs within normal limits for age. Stable, medically treated hypotension will be allowed",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "ECG must demonstrate predominately normal sinus rhythm. Minor abnormalities documented as clinically insignificant will be allowed",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Participants and their authorized representatives will provide written informed consent",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Participants who have received any experimental drug for Down syndrome must undergo a washout",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "All participants must: Be in general good health as judged by the investigators; Be able to swallow oral medication; Have a reliable caregiver or family member who agrees to accompany participant to all visits, provide information about the participant as required by the protocol, and ensure compliance with the medication schedule; Be sufficiently proficient in English (USA) or Portuguese (Brazil) to reliably complete the study assessments",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Age and gender matching participants without Down syndrome, must be: Males or females without Down syndrome aged-matching (within 3 years) participants with Down syndrome whom they are expected to serve as controls",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Participant weighing less than 40 kg",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Current psychiatric or neurologic diagnosis other than Down syndrome (e.g., major depressive disorder, schizophrenia, bipolar disorder, autism, Alzheimer disease)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current treatment with psychotropic drugs",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Drug or alcohol abuse or dependence",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Significant suicide risk or who would require treatment with electro-convulsive therapy or with psychotropic drugs during the study or who have received treatment with a depot neuroleptic drug within 6 months of entering the study.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current or expected (within the next 6 months) hospitalization or residence in a skilled nursing facility (may reside in group homes or other residential settings with no skilled nursing)",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 60-year-old Spanish man presenting with shortness of breath about a day before. He has COPD and smokes 20 cigarettes per day.",
  "_meta": {
    "topic_id": "28",
    "trial_id": "NCT02304302",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}